Lemrow Shannon M, Anderson Kristin A, Joseph James D, Ribar Thomas J, Noeldner Pamela K, Means Anthony R
Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, USA.
J Biol Chem. 2004 Mar 19;279(12):11664-71. doi: 10.1074/jbc.M312613200. Epub 2003 Dec 29.
Calcium/calmodulin-dependent protein kinase IV (CaMKIV) is a nuclear protein kinase that responds to acute rises in intracellular calcium by phosphorylating and activating proteins involved in transcription. Consistent with these roles, CaMKIV is found predominantly in the nucleus of cells in which it is expressed. Here we evaluate nuclear entry of CaMKIV and demonstrate that the protein kinase homology domain is both necessary and sufficient for nuclear localization. Unexpectedly, although catalytic activity is required for nuclear translocation, it is not required for CaMKIV to interact with the nuclear adaptor protein, importin-alpha. Because the catalytically inactive molecules remain in the cytoplasm, these data suggest that this interaction is not sufficient for nuclear entry. We evaluated a role for other proteins known to interact with CaMKIV in regulation of its nuclear entry. Although our data do not support a role for calmodulin or protein phosphatase 2A, the catalytically inactive CaMKIV proteins interact more avidly with CaM-dependent protein kinase kinase (CaMKK), which is restricted to the cytoplasm. We find that the catalytically inactive proteins do not inhibit nuclear entry of wild-type CaMKIV but do inhibit the ability of the wild-type protein kinase to stimulate cyclic AMP response element-binding protein-mediated transcription. Because activation loop phosphorylation is required for the transcriptional roles of CaMKIV, these data suggest that CaMKK phosphorylation of CaMKIV may occur in the cytoplasm. We propose that sequestration of CaMKK may be the molecular mechanism by which catalytically inactive mutants of CaMKIV exert their "dominant-negative" functions within the cell.
钙/钙调蛋白依赖性蛋白激酶IV(CaMKIV)是一种核蛋白激酶,通过磷酸化并激活参与转录的蛋白质来响应细胞内钙的急性升高。与这些作用一致,CaMKIV主要存在于其表达的细胞核中。在此,我们评估了CaMKIV的核进入情况,并证明蛋白激酶同源结构域对于核定位既是必需的也是充分的。出乎意料的是,虽然核转位需要催化活性,但CaMKIV与核适配蛋白输入蛋白α相互作用并不需要催化活性。由于催化失活的分子保留在细胞质中,这些数据表明这种相互作用不足以实现核进入。我们评估了其他已知与CaMKIV相互作用的蛋白质在其核进入调节中的作用。虽然我们的数据不支持钙调蛋白或蛋白磷酸酶2A的作用,但催化失活的CaMKIV蛋白与局限于细胞质的钙调蛋白依赖性蛋白激酶激酶(CaMKK)的相互作用更为强烈。我们发现催化失活的蛋白并不抑制野生型CaMKIV的核进入,但确实抑制野生型蛋白激酶刺激环磷酸腺苷反应元件结合蛋白介导的转录的能力。由于CaMKIV的转录作用需要激活环磷酸化,这些数据表明CaMKIV的CaMKK磷酸化可能发生在细胞质中。我们提出,CaMKK的隔离可能是CaMKIV催化失活突变体在细胞内发挥其“显性负性”功能的分子机制。